Alembic Pharmaceuticals Ltd share price logo

Alembic Pharmaceuticals Ltd Share Price (APLLTD)

₹931.053.58%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Alembic Pharmaceuticals Ltd share Performance

  • ₹925.1
    ₹960
    ₹931.05
    downward going graph

    0.64%

    Low

    Day's Volatility:3.75%

    High

    3.11%

    downward going graph
  • ₹517.05
    ₹1094
    ₹931.05
    downward going graph

    44.47%

    Low

    52 Weeks Volatility:61.97%

    High

    17.50%

    downward going graph
1 Month Return0.24 %
3 Month Return2.68 %
1 Year Return79.88 %
Previous Close₹965.60
Open₹960.00
Volume1.74L
Upper Circuit-
Lower Circuit-
Market Cap₹18,980.14Cr

Analyst Rating for Alembic Pharmaceuticals Ltd stock

based on 13 analysts

HOLD
23.08%
Buy
46.15%
Hold
30.77%
Sell

Based on 13 analysts offering long term price targets for Alembic Pharmaceuticals Ltd. An average target of ₹933.46

Source: S&P Global Market Intelligence

Company Information

Alembic Pharmaceuticals is a leading generic pharmaceuticals manufacturer and marketer based in India. Established in 2010 as a subsidiary of Alembic Ltd., they stopped being a subsidiary in 2011 when they were allotted 133515914 equity shares of Rs 2 each to their shareholders. In 2014 Alembic Pharmaceuticals entered into a joint venture with Adwiya Mami SARL, Algeria and in 2015 an exclusive agreement was signed with Novartis. In 2016, Alembic Pharmaceuticals formed Aleor Dermaceuitical Limited in a 60:40 joint venture with Orbicular and a state-of-the-art anticancer manufacturing facility opened in Gujarat in 2017. One year later Alembic Pharmaceuticals completed the acquisition of Orit Laboratories LLC, a generic drug developer, along with real estate. In 2018 Alembic Pharmaceuticals was inspected by the US FDA and were issued with 3 observations. In 2019, they launched 9 new products in the US, and the novel Umbralicib UKONIQ was licensed by TG Therapeutics USA in 2021. In 2022, Aleor Dermaceuticals was amalgamated into Alembic Pharmaceutical and became a wholly owned subsidiary.

Share Price: ₹931.05 per share as on 18 Apr, 2024 04:01 PM
Market Capitalisation: ₹18,980.14Cr as of today
Revenue: ₹1,630.57Cr as on December 2023 (Q4 23)
Net Profit: ₹180.45Cr as on December 2023 (Q4 23)
Listing date: 20 Sep, 2011
Chairperson Name: Chirayu R Amin
OrganisationAlembic Pharmaceuticals Ltd
HeadquartersVadodara
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Generates 89% TSR in Last Year - 13 Apr, 2024

    Alembic Pharmaceuticals has generated an 89% total shareholder return (TSR) over the last year, exceeding its share price return of 87%. The company's EPS grew by 179%, indicating a potential opportunity for investors. However, the market may not be as excited about Alembic Pharmaceuticals as it was before. Overall, shareholders have received better returns recently than over the past five years.

Fundamentals of Alembic Pharmaceuticals Ltd

Insights on Alembic Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.40K Cr → 1.63K Cr (in ₹), with an average increase of 4.8% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.71% to 7.82% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 120.6 Cr → 180.45 Cr (in ₹), with an average increase of 18.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, APLLTD has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.61% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 140.0% return, outperforming this stock by 143.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 4.52% to 4.46% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, APLLTD stock has moved down by -3.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 11.37% to 10.54% in Mar 2024 quarter

Alembic Pharmaceuticals Ltd Valuation

Alembic Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.53x)

March 23, 2020

Today (32.10x)

April 16, 2024

Industry (60.97x)

April 16, 2024

Highest (53.41x)

January 3, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
Kotak Small Cap Direct GrowthKotak Small Cap Direct Growth2.44%
DSP Midcap Fund Direct Plan GrowthDSP Midcap Fund Direct Plan Growth1.98%
DSP Healthcare Fund Direct GrowthDSP Healthcare Fund Direct Growth5.93%
DSP ELSS Tax Saver Fund Direct Plan GrowthDSP ELSS Tax Saver Fund Direct Plan Growth0.88%
Axis Small Cap Fund Direct GrowthAxis Small Cap Fund Direct Growth0.5%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
69.61%
0.00
Foreign Institutions
4.46%
0.00
Mutual Funds
7.82%
0.00
Retail Investors
10.54%
0.00
Others
7.57%
0.00

Technicals of Alembic Pharmaceuticals Ltd share

News & Events of Alembic Pharmaceuticals Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Alembic Pharmaceuticals Ltd shares.

Alembic Pharmaceuticals Ltd (APLLTD) share price today is ₹931.05

Alembic Pharmaceuticals Ltd is listed on NSE

Alembic Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of Alembic Pharmaceuticals Ltd is ₹960.
  • Today’s lowest price of Alembic Pharmaceuticals Ltd is ₹925.1.

PE Ratio of Alembic Pharmaceuticals Ltd is 32.1

PE ratio = Alembic Pharmaceuticals Ltd Market price per share / Alembic Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Alembic Pharmaceuticals Ltd(APLLTD) is 1.74L.

Today’s market capitalisation of Alembic Pharmaceuticals Ltd(APLLTD) is ₹18980.14Cr.

Alembic Pharmaceuticals Ltd(APLLTDPrice
52 Week High
₹1094
52 Week Low
₹517.05

Alembic Pharmaceuticals Ltd(APLLTD) share price is ₹931.05. It is down -14.89% from its 52 Week High price of ₹1094

Alembic Pharmaceuticals Ltd(APLLTD) share price is ₹931.05. It is up 80.07% from its 52 Week Low price of ₹517.05

Alembic Pharmaceuticals Ltd(APLLTDReturns
1 Day Returns
-34.55%
1 Month Returns
0.24%
3 Month Returns
2.68%
1 Year Returns
79.88%